Investors in It

At Demeter, we are a significant player in European venture capital, private equity, and infrastructure financing aimed at advancing the energy and ecological transition. Our funds invest from €1m to €30m to support companies across all stages of development: from innovative startups to small and mid-cap companies, as well as infrastructure projects. Our team, comprising 38 professionals based in Paris, Lyon, Bordeaux, Madrid, and Düsseldorf, manages €1.3bn in assets and has successfully completed 230 investments over the span of 17 years.

Created by Audacia and Rymdkapital, Expansion is a €300M VC fund dedicated to supporting European Aerospace & Defence startups from Pre-Seed to Series B stages. At Expansion, we are committed to fostering innovation and growth within the Aerospace & Defence sector through strategic investments and support.

Air Liquide is a global leader in gases, technologies, and services for industry and healthcare. Present in 72 countries with 67,800 employees, our Group serves more than 4 million customers and patients worldwide. Oxygen, nitrogen, and hydrogen are essential small molecules crucial for life, matter, and energy, representing Air Liquide’s scientific focus and central to our operations since our inception in 1902. At Air Liquide, taking proactive steps today while preparing for the future is core to our strategy. Air Liquide Venture Capital (ALIAD) was set up in 2013 as the Air Liquide Group’s venture capital arm.

In the realm of Venture Capital and Private Equity, we as principals play a pivotal role in driving investment strategies and fostering growth in dynamic companies. Our expertise lies in identifying promising opportunities, conducting thorough due diligence, and structuring deals that maximize value for our investors and portfolio companies. We leverage our network, experience, and strategic insights to navigate the complexities of investment landscapes, aiming to achieve sustainable returns and significant impact in the industries we engage with.

Early stage VC based in Prague. Strong founders with profound knowledge of the industry who aims to disrupt with investing in innovations in DACH, Baltics, CEE and UK. They invest in late seed to pre-Series A startups scaling up with 300k ARR. Their investment tickets range from 200k to 2 million. Industry agnostic.

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds. Finding and fueling tomorrow's advances in precision medicine.

We at ID4 Ventures finance and mentor young talented entrepreneurs across Europe. We bring our extensive experience, energy, and visionary approach to every partnership. Our model is mutually beneficial: we invest our time, expertise, and capital in exchange for equity, aiming to accelerate growth and ultimately realize significant returns on investment. To explore potential collaborations, please send us a presentation at

Token Ventures invest into coins and tokens as well as into HW infrastructure.Token Ventures is a diverse team specializing in venture investments in blockchain technologies, crypto infrastructure, trading, and advisory services with a focus on Web3 startups, DeFi, and NFTs.

Asterion Ventures is the first venture capital firm structured to support impact entrepreneurs from the seed phase and over the long term. We finance sustainable innovations likely to cause serial shifts and contribute to the profound transformation of the economic and social system. We back companies that create new market benchmarks, establish themselves as leaders in their sector, change the rules of the game, or lead entire industries toward better practices. At Asterion, we invest as lead investors, making 20 investments per year with ticket sizes ranging from €500,000 to €2M in pre-seed and seed rounds up to €5M. We provide patient capital over the long term, acting as a reference shareholder and maintaining our pro-rata during the series A and B rounds of our portfolio's investments throughout their value creation. Our community of seasoned investors gives their time to help our portfolio companies succeed.

We invest in Nordic ventures at the pre-seed and seed stages. We see opportunities across sectors, but look for growing categories, and disruptive business models.We look for outstanding founder teams with complementary skill sets. Being a strong founder doesn't mean you excel at everything, but it does mean that you know your strengths and weaknesses. Our structural setup allows us the flexibility to dip our toes via sensible initial investments in founders that are still finding their footing and then do significant follow-up investments when the time is right. We love to collaborate with people who can contribute positively to the success of our startups. We firmly believe this is a strength, and are proud of the results we see among our portfolio founders and the teams they build.

At Lightbird, we partner, early in the journey, with companies that lead with distribution. We believe that establishing this from the beginning is the only way to stand out in today's market. Backing Entrepreneurs Reaching for the Sky. We are in the era of the end user and their teams, where B2B software companies have to be obsessed with the person they build for. In this era, the best companies turn innovation into a go-to-market advantage. We call this: Distribution Advantage.

At 2050, we are a new kind of investment fund that combines performance and company alignment. We empower those who are building a fertile future, creating a world aligned with economic, social, and ecological challenges. Our mission is to support and invest in businesses that are committed to making a positive impact on society and the environment while achieving strong financial performance.